Type III secretion system
Type III Secretion System (T3SS), also known as the injectisome, is a complex protein structure found in many Gram-negative bacteria. It is a key virulence mechanism that allows bacteria to inject toxins directly into the cytoplasm of their host cells. The T3SS is composed of more than 20 different proteins that assemble into a needle-like structure spanning the bacterial inner membrane, periplasm, and outer membrane.
Structure and Function[edit | edit source]
The T3SS resembles a molecular syringe through which bacteria can inject effector proteins into host cells. The structure can be broadly divided into three main parts: the basal body, the needle, and the translocon. The basal body spans the bacterial inner and outer membranes, anchoring the system to the bacterium. The needle extends from the basal body and is composed of many copies of a single protein. The translocon is located at the tip of the needle and forms a pore in the host cell membrane, through which effector proteins are delivered.
Effector proteins delivered by the T3SS can manipulate host cell processes to the advantage of the infecting bacterium, including suppression of the immune response and induction of cell death. The specificity of the interaction between bacterial effectors and host cell targets is a key area of research, as it provides insights into the mechanisms of bacterial pathogenesis and host defense.
Examples of Bacteria with T3SS[edit | edit source]
Several pathogenic bacteria possess a T3SS, including:
- Salmonella spp. - causes salmonellosis
- Yersinia spp. - causes plague and gastroenteritis
- Shigella spp. - causes shigellosis
- Pseudomonas aeruginosa - a common cause of hospital-acquired infections
- Escherichia coli (certain strains) - causes severe diarrhea
Clinical Significance[edit | edit source]
The T3SS is a critical virulence factor for many bacterial pathogens. Understanding the structure and function of the T3SS can lead to the development of new therapeutic strategies, such as vaccines or drugs that inhibit the assembly or function of the secretion system. Additionally, the T3SS has been explored as a tool for the delivery of therapeutic proteins in medicine and biotechnology.
Research and Therapeutic Applications[edit | edit source]
Research on the T3SS has focused on elucidating the structure of the complex, identifying the full range of effector proteins, and understanding how these effectors manipulate host cell processes. There is also interest in exploiting the T3SS for the delivery of heterologous proteins in vaccine development, where the secretion system of attenuated bacterial strains is used to deliver antigens directly into host cells, thereby eliciting a strong immune response.
See Also[edit | edit source]
Type III secretion system Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD